Predictors of episodic migraine transformation to chronic migraine: A systematic review and meta-analysis of observational cohort studies

被引:46
|
作者
Xu, Jingjing [1 ,2 ]
Kong, Fanyi [1 ,2 ]
Buse, Dawn C. [3 ]
机构
[1] Peoples Liberat Army, Hosp Logist Support Force 920, Dept Neurol, 212 Daguan Rd, Kunming 650032, Yunnan, Peoples R China
[2] Kunming Med Univ, Sch Clin Med, Kunming, Yunnan, Peoples R China
[3] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA
关键词
Migraine; episodic migraine; chronic migraine; risk factor; predictor; meta-analysis; systematic review; CUTANEOUS ALLODYNIA; MEDICATION OVERUSE; RISK-FACTOR; HEADACHE; PREVALENCE; CHRONIFICATION; PROGRESSION; DEPRESSION; INCOME; ONSET;
D O I
10.1177/0333102419883355
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purpose An estimated 2.5-3.1% of people with episodic migraine develop chronic migraine in a year. Several risk factors are associated with an increased risk for this transformation. We conducted a systematic review and meta-analysis to provide quantitative and qualitative data on predictors of this transformation. Methods An electronic search was conducted for published, prospective, cohort studies that reported risk factors for chronic migraine among people with episodic migraine. Risk of bias was assessed using the Newcastle-Ottawa Quality Assessment Scale. Quality of evidence was determined according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) guidelines. Effect estimates were retrieved and summarized using risk ratios. Results Of 5695 identified publications, 11 were eligible for inclusion. The pooled analysis (GRADE system) found "high" evidence for monthly headache day frequency >= 10 (risk ratio = 5.95), "moderate" evidence for depression (risk ratio = 1.58), monthly headache day frequency >= 5 (risk ratio = 3.18), and annual household income >= $50,000 (risk ratio = 0.65) and "very low" evidence for allodynia (risk ratio = 1.40) and medication overuse (risk ratio = 8.82) in predicting progression to chronic migraine. Conclusions High frequency episodic migraine and depression have high quality evidence as predictors of the transformation from episodic migraine to chronic migraine, while annual household income over $50,000 may be protective.
引用
收藏
页码:503 / 516
页数:14
相关论文
共 50 条
  • [31] Safety and efficacy of galcanezumab in chronic and episodic migraine patients: a systematic review and meta-analysis of randomized controlled trials
    Zaazouee, Mohamed Sayed
    Ebrahim, Rokaya Y.
    Al-araj, Ghaida'a
    Zaki, Ibram
    Saad, Ahmed
    Farhat, Abdullah Mohamed
    Ali, Mustafa Hussein
    Elshennawy, Mohamed
    Fawy, Omar Khaled Fahmy
    Ahmed, Hadi F.
    Alahmad, Ziad
    Nada, Eman Ayman
    Abo-Hamra, Reem I.
    Elsnhory, Ahmed Bostamy
    Eleyan, Mohammed
    AbuEl-Enien, Hazem
    Elromely, Rasha Abdo
    AbdelQadir, Yossef Hassan
    Shah, Jaffer
    Elshanbary, Alaa Ahmed
    [J]. EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY, 2024, 60 (01):
  • [32] CGRP-antibodies, topiramate and botulinum toxin type A in episodic and chronic migraine: A systematic review and meta-analysis
    Frank, Florian
    Ulmer, Hanno
    Sidoroff, Victoria
    Broessner, Gregor
    [J]. CEPHALALGIA, 2021, 41 (11-12) : 1222 - 1239
  • [33] Premonitory symptoms in migraine: a systematic review and meta-analysis of observational studies reporting prevalence or relative frequency
    Eigenbrodt, Anna K.
    Christensen, Rune Hackert
    Ashina, Hakan
    Iljazi, Afrim
    Christensen, Casper Emil
    Steiner, Timothy J.
    Lipton, Richard B.
    Ashina, Messoud
    [J]. JOURNAL OF HEADACHE AND PAIN, 2022, 23 (01):
  • [34] What proportion of people with migraine report postdromal symptoms? A systematic review and meta-analysis of observational studies
    Christensen, Rune Haeckert
    Eigenbrodt, Anna Kristina
    Ashina, Hakan
    Steiner, Timothy J.
    Ashina, Messoud
    [J]. CEPHALALGIA, 2023, 43 (10)
  • [35] Premonitory symptoms in migraine: a systematic review and meta-analysis of observational studies reporting prevalence or relative frequency
    Anna K. Eigenbrodt
    Rune Häckert Christensen
    Håkan Ashina
    Afrim Iljazi
    Casper Emil Christensen
    Timothy J. Steiner
    Richard B. Lipton
    Messoud Ashina
    [J]. The Journal of Headache and Pain, 2022, 23
  • [36] Migraine, migraine aura, and cervical artery dissection: A systematic review and meta-analysis
    Rist, Pamela M.
    Diener, Hans-Christoph
    Kurth, Tobias
    Schuerks, Markus
    [J]. CEPHALALGIA, 2011, 31 (08) : 886 - 896
  • [37] Effectiveness of Calcitonin Gene-Related Peptide Monoclonal Antibodies in the Prevention of Migraine: A Systematic Review and Meta-Analysis of Observational Cohort Studies
    Ferreira, Vinicius L.
    Mainka, Felipe F.
    Wiens, Astrid
    Pontarolo, Roberto
    [J]. CLINICAL DRUG INVESTIGATION, 2023, 43 (09) : 669 - 680
  • [38] Effectiveness of Calcitonin Gene-Related Peptide Monoclonal Antibodies in the Prevention of Migraine: A Systematic Review and Meta-Analysis of Observational Cohort Studies
    Vinicius L. Ferreira
    Felipe F. Mainka
    Astrid Wiens
    Roberto Pontarolo
    [J]. Clinical Drug Investigation, 2023, 43 : 669 - 680
  • [39] The effect of blood pressure lowering medications on the prevention of episodic migraine: A systematic review and meta-analysis
    Carcel, Cheryl
    Haghdoost, Faraidoon
    Shen, Joanne
    Nanda, Puneet
    Bai, Yu
    Atkins, Emily
    Torii-Yoshimura, Takako
    Clough, Alexander J.
    Davies, Leo
    Cordato, Dennis
    Griffiths, Lyn R.
    Balicki, Grace
    Wang, Xia
    Vidyasagar, Kota
    Malavera, Alejandra
    Anderson, Craig S.
    Zagami, Alessandro S.
    Delcourt, Candice
    Rodgers, Anthony
    [J]. CEPHALALGIA, 2023, 43 (06)
  • [40] Migraine and cardiovascular disease: a systematic review and meta-analysis
    Schuerks, M.
    Rist, P. M.
    Bigal, M. E.
    Lipton, R. B.
    Buring, J. E.
    Kurth, T.
    [J]. CEPHALALGIA, 2009, 29 : 66 - 67